Erratum: Anti-tumor effects of nitrosylcobalamin against spontaneous tumors in dogs (Investigational New Drugs (2011) DOI: 10.1007/s10637-009-9282-0);Anti-tumor effects of nitrosylcobalamin against spontaneous tumors in dogs

Investigational New Drugs

Volumn 28, Issue 5, 2010, Pages 694-702

  Bauer, Joseph A ^a   Frye, Gerald ^b   Bahr, Anne ^c   Gieg, Jennifer ^d   Brofman, Peter ^e  

^a Bauer Research Foundation   (United States)

^b PetsDx Veterinary Imaging   (United States)

^c PetRays Veterinary Radiology Consultants   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e Carolina Veterinary Specialists Medical Center   (United States)

Author keywords

Apocrine gland anal sac adenocarcinoma; Chemotherapy; Nitric oxide; Nitrosylcobalamin; Schwannomas; Thyroid carcinoma; Vitamin B12

Indexed keywords

CARBOPLATIN; COBALAMIN; CYANOCOBALAMIN RECEPTOR; DOXORUBICIN; DRUG CARRIER; LIVER ENZYME; MITOXANTRONE; NITRIC OXIDE; NITROSYLCOBALAMIN; UNCLASSIFIED DRUG; VITAMIN RECEPTOR; ANTINEOPLASTIC AGENT; CYANOCOBALAMIN; NITROSO DERIVATIVE;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOCRINE GLAND ANAL SAC ADENOCARCINOMA; ARTICLE; CANCER REGRESSION; CANCER SIZE; CONTROLLED STUDY; DOG; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG HALF LIFE; DRUG RESPONSE; FEMALE; LONG TERM CARE; MALE; MENINGIOMA; MULTIPLE CYCLE TREATMENT; NERVE SHEATH TUMOR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHAGOCYTOSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THYROID CARCINOMA; TUMOR; ULTRASOUND; ANALOGS AND DERIVATIVES; ANIMAL; CASE REPORT; DOG DISEASES; DOSE RESPONSE; ECHOGRAPHY; METABOLISM; NEOPLASMS; PATHOLOGY; TUMOR VOLUME; VETERINARY;

ANIMALS; ANTINEOPLASTIC AGENTS; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASMS; NITROSO COMPOUNDS; TUMOR BURDEN; VITAMIN B 12;

EID: 77956058198     PISSN: 01676997     EISSN: 15730646     Source Type: Journal    
DOI: 10.1007/s10637-011-9664-y     Document Type: Erratum

References (47)

1. JA Bauer BH Morrison RW Grane, et al. 2002 Effects of interferon beta on transcobalamin II-receptor expression and antitumor activity of nitrosylcobalamin J Natl Cancer Inst 94 13 1010 1019 1:CAS:528: DC%2BD38Xlsl2hsbo%3D 12096086
2. DA Collins HP Hogenkamp 1997 Transcobalamin II receptor imaging via radiolabeled diethylene- triaminepentaacetate cobalamin analogs J Nucl Med 38 5 717 723 1:CAS:528:DyaK2sXjsVOkuro%3D 9170435
3. DA Collins HP Hogenkamp MK O'Connor, et al. 2000 Biodistribution of radiolabeled adenosylcobalamin in patients diagnosed with various malignancies Mayo Clin Proc 75 6 568 580 10.4065/75.6.568 1:CAS:528:DC%2BD3cXptVegsrs%3D 10852417
4. M Chawla-Sarkar JA Bauer JA Lupica, et al. 2003 Suppression of NF-kappa B survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL The Journal of biological chemistry 278 41 39461 39469 10.1074/jbc.M306111200 1:CAS:528:DC%2BD3sXnvFant70%3D 12881518
5. JA Bauer JA Lupica H Schmidt, et al. 2007 Nitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signaling PLoS ONE 2 12 e1313 10.1371/journal.pone.0001313 18074035
6. Z Tang JA Bauer B Morrison DJ Lindner 2006 Nitrosylcobalamin promotes cell death via S nitrosylation of Apo2L/TRAIL receptor DR4 Mol Cell Biol 26 15 5588 5594 10.1128/MCB.00199-06 1:CAS:528:DC%2BD28Xns1Cgu7o%3D 16847314
7. A Ashkenazi RC Pai S Fong, et al. 1999 Safety and antitumor activity of recombinant soluble Apo2 ligand Journal of Clinical Investigation 104 2 155 162 10.1172/JCI6926 1:CAS:528:DyaK1MXkslSmsbw%3D 10411544
8. A Ashkenazi 2002 Targeting death and decoy receptors of the tumour-necrosis factor superfamily Nature Reviews Cancer 2 6 420 430 10.1038/nrc821 1:CAS:528:DC%2BD38Xksl2ltr4%3D 12189384
9. JA Bauer 1998 Synthesis, characterization and nitric oxide release profile of nitrosylcobalamin: a potential chemotherapeutic agent Anticancer Drugs 9 3 239 244 10.1097/00001813-199803000-00006 1:CAS:528:DyaK1cXislKntbw%3D 9625434
10. JE de La Coussaye P Houeto P Sandouk P Levillain A Sassine B Riou 1994 Pharmacokinetics of hydroxocobalamin in dogs J Neurosurg Anesthesiol 6 2 111 115
11. DM Brehm CH Vite HS Steinberg J Haviland T van Winkle 1995 A retrospective evaluation of 51 cases of peripheral nerve sheath tumors in the dog J Am Anim Hosp Assoc 31 4 349 359 1:STN:280:DyaK28%2FjsFSluw%3D%3D 7552669
12. JM Liptak 2007 Canine thyroid carcinoma Clin Tech Small Anim Pract 22 2 75 81 10.1053/j.ctsap.2007.03.007 17591293
13. MK Klein BE Powers SJ Withrow, et al. 1995 Treatment of thyroid carcinoma in dogs by surgical resection alone: 20 cases (1981-1989) J Am Vet Med Assoc 206 7 1007 1009 1:STN:280:DyaK2M3os1ertg%3D%3D 7768706
14. JM Turrel MC McEntee BP Burke RL Page 2006 Sodium iodide I 131 treatment of dogs with nonresectable thyroid tumors: 39 cases (1990-2003) J Am Vet Med Assoc 229 4 542 548 10.2460/javma.229.4.542 1:CAS:528:DC%2BD28Xptlehur4%3D 16910854
15. AJ Worth RM Zuber M Hocking 2005 Radioiodide (131I) therapy for the treatment of canine thyroid carcinoma Aust Vet J 83 4 208 214 10.1111/j.1751-0813.2005.tb11650.x 1:CAS:528:DC%2BD2MXhtlaisb7O 15907038
16. L Pack RE Roberts SD Dawson HD Dookwah 2001 Definitive radiation therapy for infiltrative thyroid carcinoma in dogs Vet Radiol Ultrasound 42 5 471 474 10.1111/j.1740-8261.2001.tb00972.x 1:STN:280:DC%2BD3MrntVKjsQ%3D%3D 11678572
17. MJ Brearley AM Hayes S Murphy 1999 Hypofractionated radiation therapy for invasive thyroid carcinoma in dogs: a retrospective analysis of survival J Small Anim Pract 40 5 206 210 10.1111/j.1748-5827.1999.tb03061.x 1:STN:280:DyaK1MzhtlKnsg%3D%3D 10385862
18. LS Fineman TA Hamilton A de Gortari P Bonney 1998 Cisplatin chemotherapy for treatment of thyroid carcinoma in dogs: 13 cases J Am Anim Hosp Assoc 34 2 109 112 1:STN:280:DyaK1c7mvValtw%3D%3D 9507422
19. DW Knapp RC Richardson PL Bonney K Hahn 1988 Cisplatin therapy in 41 dogs with malignant tumors J Vet Intern Med 2 1 41 46 10.1111/j.1939-1676.1988. tb01976.x 1:STN:280:DyaL1M7isFCmtw%3D%3D 3221354
20. AS Hammer CG Couto RD Ayl KA Shank 1994 Treatment of tumor-bearing dogs with actinomycin D J Vet Intern Med 8 3 236 239 10.1111/j.1939-1676.1994. tb03224.x 1:STN:280:DyaK2czktleisg%3D%3D 8064663
21. GK Ogilvie JE Obradovich RE Elmslie, et al. 1991 Efficacy of mitoxantrone against various neoplasms in dogs J Am Vet Med Assoc 198 9 1618 1621 1:STN:280:DyaK3M3os1SisA%3D%3D 2061177
22. GK Ogilvie HA Reynolds RC Richardson, et al. 1989 Phase II evaluation of doxorubicin for treatment of various canine neoplasms J Am Vet Med Assoc 195 11 1580 1583 1:STN:280:DyaK3c%2Fptl2ktw%3D%3D 2599941
23. KAWA Jeglum 1982 Chemotherapy of canine thyroid carcinoma Compend Contin Educ Pract Vet 5 96 98
24. RS Bagley SJ Wheeler L Klopp, et al. 1998 Clinical features of trigeminal nerve-sheath tumor in 10 dogs J Am Anim Hosp Assoc 34 1 19 25 1:STN:280:DyaK1c7jvVyqug%3D%3D 9527425
25. MS Levy AS Kapatkin AK Patnaik GN Mauldin GE Mauldin 1997 Spinal tumors in 37 dogs: clinical outcome and long-term survival (1987-1994) J Am Anim Hosp Assoc 33 4 307 312 1:STN:280:DyaK2szkvVCmtw%3D%3D 9204465
26. M Kuwamura J Yamate T Kotani T Takeuchi S Sakuma 1998 Canine peripheral nerve sheath tumor with eosinophilic cytoplasmic globules Vet Pathol 35 3 223 226 10.1177/030098589803500309 1:STN:280:DyaK1c3lvVGgtg%3D%3D 9598587
27. K Chijiwa K Uchida S Tateyama 2004 Immunohistochemical evaluation of canine peripheral nerve sheath tumors and other soft tissue sarcomas Vet Pathol 41 4 307 318 10.1354/vp.41-4-307 1:STN:280:DC%2BD2czjtVKkug%3D%3D 15232130
28. MH Goldschmidt C Zoltowski 1981 Anal sac gland adenocarcinoma in the dog: 14 cases J Small Anim Pract 22 3 119 128 10.1111/j.1748-5827.1981.tb00591.x 1:STN:280:DyaL3M7psFOltg%3D%3D 7230749
29. PF Bennett DB DeNicola P Bonney NW Glickman DW Knapp 2002 Canine anal sac adenocarcinomas: clinical presentation and response to therapy J Vet Intern Med 16 1 100 104 11822797
30. SG Emms 2005 Anal sac tumours of the dog and their response to cytoreductive surgery and chemotherapy Aust Vet J 83 6 340 343 10.1111/j.1751-0813.2005.tb15626.x 1:STN:280:DC%2BD2MzjsF2htA%3D%3D 15986909
31. HP Hobson MR Brown KS Rogers 2006 Surgery of metastatic anal sac adenocarcinoma in five dogs Vet Surg 35 3 267 270 10.1111/j.1532-950X.2006. 00137.x 16635006
32. LE Williams JM Gliatto RK Dodge, et al. 2003 Carcinoma of the apocrine glands of the anal sac in dogs: 113 cases (1985-1995) J Am Vet Med Assoc 223 6 825 831 10.2460/javma.2003.223.825 14507100
33. J Ross T Scavelli D Mathiesen A Patnaik 1991 Adenocarcinoma of the apocrine glands of the anal sac in dogs: a review of 32 cases J Am Anim Hosp Assoc 27 349 355
34. Brearly M, Freeman J (1999) Anal sac adenocarcinoma in dogs: a review of 16 cases. Proceedings of the Veterinary Cancer Society 39
35. M Turek L Forrest WM Adams S Helfand DM Vail 2003 Postoperative radiotherapy and mitoxantrone for anal sac adenocarcinoma in the dog: 15 cases (1991-2001) Veterinary and Comparative Oncology 1 2 94 104 10.1046/j.1476-5829. 2003.00013.x 1:CAS:528:DC%2BD2cXosVyhur8%3D 19379321
36. J Tomlinson 1996 Surgical conditions of the cervical spine Semin Vet Med Surg (Small Anim) 11 4 225 234 1:STN:280:DyaK2s7nt1KrtA%3D%3D
37. MS Levy AS Kapatkin AK Patnaik GN Mauldin GE Mauldin 1997 Spinal tumors in 37 dogs: clinical outcome and long-term survival (1987-1994) J Am Anim Hosp Assoc 33 4 307 312 1:STN:280:DyaK2szkvVCmtw%3D%3D 9204465
38. JM Fingeroth RG Prata AK Patnaik 1987 Spinal meningiomas in dogs: 13 cases (1972-1987) J Am Vet Med Assoc 191 6 720 726 1:STN:280: DyaL1c%2FlvVekuw%3D%3D 3679964
39. FA Zaki RG Prata AI Hurvitz WJ Kay 1975 Primary tumors of the spinal cord and meninges in six dogs J Am Vet Med Assoc 166 5 511 517 1:STN:280: DyaE2M%2FpsFaktQ%3D%3D 1112759
40. KA Hahn L Bravo WH Adams DL Frazier 1994 Naturally occurring tumors in dogs as comparative models for cancer therapy research In Vivo 8 1 133 143 1:STN:280:DyaK2czjtFGrsA%3D%3D 8054503
41. A Porrello P Cardelli EP Spugnini 2004 Pet models in cancer research: general principles J Exp Clin Cancer Res 23 2 181 193 1:STN:280: DC%2BD2cvks1yjug%3D%3D 15354401
42. K Hansen C Khanna 2004 Spontaneous and genetically engineered animal models; use in preclinical cancer drug development Eur J Cancer 40 6 858 880 10.1016/j.ejca.2003.11.031 1:CAS:528:DC%2BD2cXivVCksLo%3D 15120042
43. DM Vail EG MacEwen 2000 Spontaneously occurring tumors of companion animals as models for human cancer Cancer Invest 18 8 781 792 10.3109/07357900009012210 1:STN:280:DC%2BD3M%2FmsVyjsA%3D%3D 11107448
44. MP Starkey TJ Scase CS Mellersh S Murphy 2005 Dogs really are man's best friend - canine genomics has applications in veterinary and human medicine! Brief Funct Genomic Proteomic 4 2 112 128 10.1093/bfgp/4.2.112 1:CAS:528:DC%2BD2MXhtVGgsLnN 16102268
45. A Porrello P Cardelli EP Spugnini 2006 Oncology of companion animals as a model for humans. an overview of tumor histotypes J Exp Clin Cancer Res 25 1 97 105 1:STN:280:DC%2BD28zkvVamug%3D%3D 16761625
46. GS Mack 2006 Clinical trials going to the dogs: canine program to study tumor treatment, biology J Natl Cancer Inst 98 3 161 162 10.1093/jnci/djj061 16449674
47. GS Mack 2005 Cancer researchers usher in dog days of medicine Nat Med 11 10 1018 16211022